Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ziding Feng

Showing results (251-260 of 288) with videos related to

Pageof 29
Sort By:
Hepatology (Baltimore, Md.)|August 20, 2025
Value of HCC surveillance in a landscape of emerging surveillance options: Perspectives of a multi-stakeholder modified Delphi panelAmit G Singal, Lisa Quirk, Justin Boike, et al.
The Prostate|May 6, 2015
A multicenter study shows PTEN deletion is strongly associated with seminal vesicle involvement and extracapsular extension in localized prostate cancerDean A Troyer, Tamara Jamaspishvili, Wei Wei, et al.
The Prostate|June 30, 2018
A five-CpG DNA methylation score to predict metastatic-lethal outcomes in men treated with radical prostatectomy for localized prostate cancerShanshan Zhao, Amy Leonardson, Milan S Geybels, et al.
Journal of the National Cancer Institute|April 5, 2017
Sequential Validation of Blood-Based Protein Biomarker Candidates for Early-Stage Pancreatic CancerMichela Capello, Leonidas E Bantis, Ghislaine Scelo, et al.
Disease Markers|July 20, 2004
Serum protein expression profiling for cancer detection: validation of a SELDI-based approach for prostate cancerWilliam E Grizzle, Bao-Ling L Adam, William L Bigbee, et al.
Journal of the National Cancer Institute|August 24, 2018
A Plasma-Derived Protein-Metabolite Multiplexed Panel for Early-Stage Pancreatic CancerJohannes F Fahrmann, Leonidas E Bantis, Michela Capello, et al.
Plos One|April 3, 2008
Three-tiered risk stratification model to predict progression in Barrett's esophagus using epigenetic and clinical featuresFumiaki Sato, Zhe Jin, Karsten Schulmann, et al.
Clinical Chemistry|November 21, 2007
SELDI-TOF MS whole serum proteomic profiling with IMAC surface does not reliably detect prostate cancerDale McLerran, William E Grizzle, Ziding Feng, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 14, 2016
Analytic validation of a clinical-grade PTEN immunohistochemistry assay in prostate cancer by comparison with PTEN FISHTamara L Lotan, Wei Wei, Olga Ludkovski, et al.
The Prostate|June 22, 2016
Loss of Expression of AZGP1 Is Associated With Worse Clinical Outcomes in a Multi-Institutional Radical Prostatectomy CohortJames D Brooks, Wei Wei, Jonathan R Pollack, et al.
Pageof 29

Showing results (251-260 of 288) with videos related to

Sort By:
Pageof 29
Hepatology (Baltimore, Md.)|August 20, 2025
Value of HCC surveillance in a landscape of emerging surveillance options: Perspectives of a multi-stakeholder modified Delphi panelAmit G Singal, Lisa Quirk, Justin Boike, et al.
The Prostate|May 6, 2015
A multicenter study shows PTEN deletion is strongly associated with seminal vesicle involvement and extracapsular extension in localized prostate cancerDean A Troyer, Tamara Jamaspishvili, Wei Wei, et al.
The Prostate|June 30, 2018
A five-CpG DNA methylation score to predict metastatic-lethal outcomes in men treated with radical prostatectomy for localized prostate cancerShanshan Zhao, Amy Leonardson, Milan S Geybels, et al.
Journal of the National Cancer Institute|April 5, 2017
Sequential Validation of Blood-Based Protein Biomarker Candidates for Early-Stage Pancreatic CancerMichela Capello, Leonidas E Bantis, Ghislaine Scelo, et al.
Disease Markers|July 20, 2004
Serum protein expression profiling for cancer detection: validation of a SELDI-based approach for prostate cancerWilliam E Grizzle, Bao-Ling L Adam, William L Bigbee, et al.
Journal of the National Cancer Institute|August 24, 2018
A Plasma-Derived Protein-Metabolite Multiplexed Panel for Early-Stage Pancreatic CancerJohannes F Fahrmann, Leonidas E Bantis, Michela Capello, et al.
Plos One|April 3, 2008
Three-tiered risk stratification model to predict progression in Barrett's esophagus using epigenetic and clinical featuresFumiaki Sato, Zhe Jin, Karsten Schulmann, et al.
Clinical Chemistry|November 21, 2007
SELDI-TOF MS whole serum proteomic profiling with IMAC surface does not reliably detect prostate cancerDale McLerran, William E Grizzle, Ziding Feng, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 14, 2016
Analytic validation of a clinical-grade PTEN immunohistochemistry assay in prostate cancer by comparison with PTEN FISHTamara L Lotan, Wei Wei, Olga Ludkovski, et al.
The Prostate|June 22, 2016
Loss of Expression of AZGP1 Is Associated With Worse Clinical Outcomes in a Multi-Institutional Radical Prostatectomy CohortJames D Brooks, Wei Wei, Jonathan R Pollack, et al.
Pageof 29